Kim Jeong Kon, Kim Soo Hyun, Jang Yoon Jin, Ahn Hanjong, Kim Choung-Soo, Park Hyungkeun, Lee Jun Woo, Kim Suk, Cho Kyoung-Sik
Departments of Radiology and Urology, Asan Medical Center, University of Ulsan, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, South Korea.
Radiology. 2006 Apr;239(1):174-80. doi: 10.1148/radiol.2391050102. Epub 2006 Feb 28.
To prospectively evaluate the diagnostic performance of double-echo gradient-echo (GRE) chemical shift magnetic resonance (MR) imaging in the differentiation of angiomyolipoma (AML) with minimal fat from other renal neoplasms, with pathologic examination or follow-up data serving as the reference standard.
Institutional review board approval and informed consent were obtained. Double-echo GRE chemical shift MR imaging was performed in 55 patients (29 men and 26 women; mean age, 49 years +/- 14 [standard deviation]) with 55 renal tumors, including 37 (67%) pathologically proved tumors (23 renal cell carcinomas, nine AMLs, two oncocytomas, two lymphomas, and one reninoma) and 18 (33%) clinically diagnosed tumors (17 AMLs and one indeterminate malignancy). All tumors showed no intratumoral fat and had homogeneous enhancement and a prolonged or gradual enhancement pattern on biphasic helical computed tomographic scans. Signal intensity was measured in the renal tumor and spleen on in-phase and opposed-phase images. The signal intensity index and tumor-to-spleen ratio in AMLs and non-AMLs were calculated and compared with the Student t test. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic accuracy of the signal intensity index and tumor-to-spleen ratio and to extract the optimal cut-off values in the differentiation of AMLs and non-AMLs.
The signal intensity index and tumor-to-spleen ratio were different between AMLs (42% +/- 11 and -43% +/- 17, respectively) and non-AMLs (5% +/- 14 and -4% +/- 16, respectively) (P < .001). The area under the ROC curve was 0.975 for the signal intensity index and 0.952 for the tumor-to-spleen ratio. For differentiation of AMLs from non-AMLs, sensitivity and specificity were (a) 96% and 93%, respectively, with a signal intensity index of 25% and (b) 88% and 97%, respectively, with a tumor-to-spleen ratio of -32%.
Double-echo GRE chemical shift MR imaging can be used to differentiate AML with minimal fat from other renal neoplasms.
前瞻性评估双回波梯度回波(GRE)化学位移磁共振(MR)成像在鉴别脂肪含量极少的血管平滑肌脂肪瘤(AML)与其他肾肿瘤中的诊断性能,以病理检查或随访数据作为参考标准。
获得机构审查委员会批准并取得知情同意。对55例患者(29例男性和26例女性;平均年龄49岁±14[标准差])的55个肾肿瘤进行双回波GRE化学位移MR成像,其中包括37个(67%)经病理证实的肿瘤(23例肾细胞癌、9例AML、2例嗜酸细胞瘤、2例淋巴瘤和1例肾素瘤)和18个(33%)临床诊断的肿瘤(17例AML和1例未明确的恶性肿瘤)。所有肿瘤在双期螺旋计算机断层扫描上均未显示瘤内脂肪,具有均匀强化且呈延迟或渐进性强化模式。在同相位和反相位图像上测量肾肿瘤和脾脏的信号强度。计算AML和非AML的信号强度指数及肿瘤与脾脏比值,并采用Student t检验进行比较。进行受试者操作特征(ROC)分析以评估信号强度指数和肿瘤与脾脏比值的诊断准确性,并提取鉴别AML和非AML的最佳截断值。
AML(分别为42%±11和-43%±17)与非AML(分别为5%±14和-4%±16)之间的信号强度指数及肿瘤与脾脏比值存在差异(P<.001)。信号强度指数的ROC曲线下面积为0.975,肿瘤与脾脏比值的ROC曲线下面积为0.952。对于鉴别AML与非AML,(a)信号强度指数为25%时,敏感性和特异性分别为96%和93%;(b)肿瘤与脾脏比值为-32%时,敏感性和特异性分别为88%和97%。
双回波GRE化学位移MR成像可用于鉴别脂肪含量极少的AML与其他肾肿瘤。